TiO2 microspheres containing magnetic nanoparticles for intra‐arterial hyperthermia
Source abstract
Abstract
Abstract Magnetic microspheres measuring 15–35 µm in diameter are believed to be useful for intra‐arterial hyperthermia. In this study, we attempted to prepare titanium dioxide (TiO2) microspheres containing magnetic nanoparticles (MNPs). MNP‐containing TiO2 microspheres with diameters of approximately 30 µm were successfully obtained by sol–gel reaction of titanium tetraisopropoxide in a water‐in‐oil emulsion with added cosurfactant of 1‐butanol and subsequent heat treatment at 200°C. The microspheres showed ferrimagnetism owing to high content of MNPs in approximately 60 wt % and had a low‐crystalline TiO2 matrix. Furthermore, the agar phantom was heated to above 43°C after approximately 1 min under an alternating magnetic field of 100 kHz and 300 Oe and showed in vitro biocompatibility similar to that of MNP‐free TiO2 microspheres. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 2308–2314, 2017.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Ultrasound and Hyperthermia Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Graduate School of Dentistry Tohoku University Sendai 980‐8575 Japan
Graduate School of Biomedical Engineering Tohoku University Sendai 980‐8579 Japan
School of Chemistry and Chemical Engineering Guangxi University Nanning 530004 China
Graduate School of Life Science and Systems Engineering Kyushu Institute of Technology Kitakyushu 808‐0196 Japan
Funding
Japan Health Sciences Foundation
References (29)
Show source-provided references
1. 10.1016/S0304-8853(00)01239-710.1016/S0304-8853(00)01239-7 ↗
2. 10.1016/j.msec.2010.04.01610.1016/j.msec.2010.04.016 ↗
3. 10.1080/0265673050015836010.1080/02656730500158360 ↗
4. 10.1080/0265673080210475710.1080/02656730802104757 ↗
5. 10.1016/j.biomaterials.2008.09.04410.1016/j.biomaterials.2008.09.044 ↗
6. 10.1016/j.catcom.2011.08.03910.1016/j.catcom.2011.08.039 ↗
7. 10.1016/j.biomaterials.2004.07.01410.1016/j.biomaterials.2004.07.014 ↗
8. 10.1088/1748-6041/5/6/06501010.1088/1748-6041/5/6/065010 ↗
9. 10.1007/s10856-012-4735-y10.1007/s10856-012-4735-y ↗
10. 10.2109/jcersj2.118.46710.2109/jcersj2.118.467 ↗
11. 10.1007/s10971-015-3680-x10.1007/s10971-015-3680-x ↗
12. 10.1097/01.RVI.0000233785.75257.9A10.1097/01.RVI.0000233785.75257.9A ↗
13. 10.1053/j.gastro.2009.09.00610.1053/j.gastro.2009.09.006 ↗
14. 10.1021/j100251a03110.1021/j100251a031 ↗
15. 10.1103/PhysRevLett.65.334810.1103/PhysRevLett.65.3348 ↗
16. 10.1016/j.crci.2003.07.02010.1016/j.crci.2003.07.020 ↗
17. 10.1016/j.colsurfa.2005.04.03210.1016/j.colsurfa.2005.04.032 ↗
18. 10.1007/s10856-007-3262-810.1007/s10856-007-3262-8 ↗
19. 10.2307/357587410.2307/3575874 ↗
20. 10.2353/jmoldx.2008.07013110.2353/jmoldx.2008.070131 ↗
21. 10.2131/jts.34.46910.2131/jts.34.469 ↗
22. 10.1021/cm960157j10.1021/cm960157j ↗
23. 10.1016/j.jmmm.2006.11.17910.1016/j.jmmm.2006.11.179 ↗
24. 10.1615/CritRevTherDrugCarrierSyst.v16.i5.2010.1615/CritRevTherDrugCarrierSyst.v16.i5.20 ↗
25. 10.1208/s12249-008-9178-x10.1208/s12249-008-9178-x ↗
26. 10.1021/jp952263z10.1021/jp952263z ↗
27. 10.1016/S0921-5107(02)00403-810.1016/S0921-5107(02)00403-8 ↗
28. 10.1016/S0304-8853(02)01279-910.1016/S0304-8853(02)01279-9 ↗
29. 10.1002/wnan.5110.1002/wnan.51 ↗